Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000947871-18-000043
Filing Date
2018-01-17
Accepted
2018-01-17 17:19:55
Documents
3
Group Members
SAMUEL D. ISALY

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 ss75697_sc13da.htm SC 13D/A 154276
2 JOINT FILING AGREEMENT ss75697_ex9901.htm EX-99.1 6988
3 SIXTH AMENDMENT ss75697_ex9916.htm EX-99.16 38798
  Complete submission text file 0000947871-18-000043.txt   201762
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

EIN.: 133976876 | State of Incorp.: DE
Type: SC 13D/A

Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Subject) CIK: 0001453593 (see all company filings)

EIN.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-86224 | Film No.: 18532244
SIC: 2836 Biological Products, (No Diagnostic Substances)